Published

Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychopharmacology (Oxford, England)
Date: 2013-09-01
Source: PubMed
DOI: 10.1177/0269881113494107
PubMed: 23784738

Authors

Carhart-Harris RL Brugger S Nutt DJ Stone JM

Watch author

Derived topics and classifications

psilocybin Depression Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models2023-09-01 Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.2013-09-01

Related papers

"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.Cannabis and cannabinoid research · 2018-01-01 Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-19 Cannabis as entheogen: survey and interview data on the spiritual use of cannabis.Journal of cannabis research · 2020-09-22 Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used Psilocybin.Cannabis and cannabinoid research · 2026-06-01 Pilot Study of Psilocybin-assisted Treatment for Cannabis Use DisorderClinicalTrials.gov · 2026-03-18 An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept StudyClinicalTrials.gov · 2025-03-19